Archive for February, 2013
-
Macromolecular Prodrugs of Ribavirin Combat Side Effects and Toxicity with No Loss of Activity of the Drug
The first publication outlining our efforts to utilize polymer therapeutics in antiviral therapy has been published in Chemical Communications. The article is entitled “Macromolecular Prodrugs of Ribavirin Combat Side Effects […]
![The first publication outlining our efforts to utilize polymer therapeutics in antiviral therapy has been published in Chemical Communications. The article is entitled “Macromolecular Prodrugs of Ribavirin Combat Side Effects […]](http://www.zelikin-lab.com/wp-content/uploads/2013/02/RBV-and-RBCs-195x110.png "Macromolecular Prodrugs of Ribavirin Combat Side Effects and Toxicity with No Loss of Activity of the Drug")
![Our work on “Molecular, Macromolecular, and Supramolecular Glucuronide Prodrugs: Lead Identified for Anticancer Prodrug Monotherapy” has been recently published in Angewande Chemie. In this work, a tumor growth intervention by […]](http://www.zelikin-lab.com/wp-content/uploads/2020/03/Artboard-3_TOC_MacroGlucuronides_-36x36.png "New publication: Angewandte Chemie"){kind=small}